Ron Hashmonay

Treatment benefit of dapoxetine for premature ejaculation: results from a placebo‐controlled phase III trial

Joel M. Kaufman, Raymond C. Rosen, Ramagopal V. Mudumbi et al. · British Journal of Urology · 2008 · 105 citations

Medicine, Pharmacology, Pharmacotherapy +17

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Pravin U. Dugel, Jost Hillenkamp, Sobha Sivaprasad et al. · Clinical ophthalmology · 2016 · 79 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Eric H. Souied, Pravin U. Dugel, Alberto Ferreira et al. · Ophthalmic Epidemiology · 2016 · 64 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial

Jonathan Calkwood, Bruce Cree, Heidi Crayton et al. · BMC Neurology · 2014 · 37 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)

Bhupendra Khatri, Jean Pelletier, Ludwig Kappos et al. · Multiple Sclerosis and Related Disorders · 2013 · 15 citations

Pharmacy, Neurology, Pharmacotherapy +12